MENSINGER MIKE (Chief Product Officer) sold 2.3% of their position (4.38K shares) of BETA BIONICS, INC. on the open market
Open‑market sale worth $55.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/3/2026ACC: 0002048500-26-000009
Officer· Chief Product Officer
Since Feb 2026
-4.38K
Net shares
Net seller
$55.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.38K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.38K
Price / share
$12.61
Trade value
$55.19K
% of position
2.3%
6/2/2026
188.79K→184.41K
Total
Net shares
−4.38K
Net value
-$55.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/2/2026 | S · Sale | −4.38K | $12.61 | $55.19K | 2.3% | 188.79K | 184.41K |
| Total | −4.38K | -$55.19K | ||||||
Derivative Transactions0
No derivative transactions reported